D.A. Davidson & Co’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

D.A. Davidson & Co’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-825	Closed	-$92K	–	2056
2017 Q2	$92K	Hold	825	–	–	﹤0.01%	1301
2017 Q1	$96K	Sell	825 -7	-0.8%	-$775	﹤0.01%	1265
2016 Q4	$86K	Buy	832 +807	+3,228%	+$84.5K	﹤0.01%	1366
2016 Q3	$2K	Sell	25 -40	-62%	-$5.3K	﹤0.01%	2308
2016 Q2	$9K	Sell	65 -15	-19%	-$2.13K	﹤0.01%	1994
2016 Q1	$10K	Sell	80 -70	-47%	-$9.94K	﹤0.01%	1913
2015 Q4	$23K	Sell	150 -120	-44%	-$17.5K	﹤0.01%	1673
2015 Q3	$38K	Sell	270 -390	-59%	-$54.5K	﹤0.01%	1481
2015 Q2	$94K	Buy	+660	New	+$94.1K	﹤0.01%	1175
2014 Q3	–	Sell	-36	Closed	-$5K	–	2194
2014 Q2	$5K	Sell	36 -161	-82%	-$17.9K	﹤0.01%	1923
2014 Q1	$21K	Hold	197	–	–	﹤0.01%	1629
2013 Q4	$19K	Buy	+197	New	+$17.1K	﹤0.01%	1573

Other funds holding TARO

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

D.A. Davidson & Co's TARO Position: Q3 2017 in Review

D.A. Davidson & Co sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2017, closing a stake of 825 shares — an estimated $92K sold.

D.A. Davidson & Co first reported a position in TARO in Q4 2013 and held it in 12 quarters. The position peaked at $96K in Q1 2017. 133 funds tracked by Wall St. Rank hold TARO as of Q3 2017.

D.A. Davidson & Co reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2017 after selling out during the quarter.
D.A. Davidson & Co sold 825 Taro Pharmaceutical Industries Ltd. shares in Q3 2017, an estimated $92K.
D.A. Davidson & Co first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2013 and held it in 12 quarters.
D.A. Davidson & Co's Taro Pharmaceutical Industries Ltd. position peaked at $96K in Q1 2017.
133 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2017.

Based on D.A. Davidson & Co's 13F filing for Q3 2017, filed 8 Nov 2017.